Mitsubishi Tanabe Pharma Development America, one of the companies of Mitsubishi Chemical Group, based in USA, sponsors research projects into the following different therapeutic areas :
- Autoimmune Diseases
- Central Nervous System Diseases
- Metabolic/Genetic Disorders
- Vaccines
Mitsubishi Tanabe Pharma Europe (MTPE) contributes to the development of compounds, managing studies in the early phase of clinical development, including healthy volunteer studies and Proof of concept, and in Late Phase patient studies (Phase 2 and Phase 3 studies) in support of marketing submissions.
Currently MTPE is supporting the development of compounds in the following disease areas:
- Amyotrophic Lateral Sclerosis (Motor Neuron Disease)
- Diffuse Cutaneous Systemic Sclerosis (Scleroderma)
- Erythropoietic Protoporphyria
- X-Linked Protoporphyria
If you would like further information please contact us on medinfo@mt-pharma-eu.com